Hazem Khamaisie

Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study

Einav Ratzon, Yousef Najajreh, Rami F. Salem et al. · BMC Cancer · 2016 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a “bedside-to-bench” approach

Eran Ben‐Arye, Ofer Lavie, Noah Samuels et al. · Medical Oncology · 2017 · 29 citations

Medicine, Gynecology, Oncology +15

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K

Afsar Mian, Isabella Haberbosch, Hazem Khamaisie et al. · Annals of Hematology · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13

Oleic acid is the active component in the mushroom Daedalea gibbosa inhibiting Bcr-Abl kinase autophosphorylation activity.

Hazem Khamaisie, Sherbel Sussan, Michael Tal et al. · PubMed · 2011 · 11 citations

Medicine, Oncology, Pharmacology +13

Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential

Noa Kidan, Hazem Khamaisie, Nili Ruimi et al. · Journal of Cancer · 2017 · 11 citations · Full text

Life Sciences, Cell Biology, Oncology +17